In a new study led by the UCLA Health Jonsson Comprehensive Cancer Center, investigators show that using advanced MRI imaging and targeted focal therapy can help many men with low- to intermediate-risk prostate cancer safely stay on active surveillance long-term, helping avoid follow-up biopsies and delay—or even avoid—invasive treatments like surgery or radiation.
This article was originally published on MedicalXpress.com